On the previous basis it appears interesting to propose the inclusion of the SLC19A2 gene in the panels of candidate genes used for the diagnosis of complex diseases associating bone marrow failure, diabetes and hearing loss and, possibly, developmental anomalies of heart and bones (microcephaly). Here, SLC19A2 is linked to diabetes mellitus.